Condition: Hidradenitis Suppurativa · Sponsor: Sanofi
This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in participants with moderate to severe hidradenitis suppurativa. The purpose of the main study is to assess the efficacy and safety of brivekimig in a dose-ranging study of participants with moderate to severe HS. Study details include: The study duration (per participant) will be up to approximately 60 weeks for participants not transitioning into the long-term extension (LTE) study and will be up to approximately 52 weeks for participants transitioning into the LTE study. The randomized treatment duration will be up to approximately 48 weeks.
This description comes directly from the study's public registry record.
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · contact-us@sanofi.com
Always discuss trial participation with your own doctor first.
| Medical Dermatology Specialists - Site Number: 8400019 | Phoenix, Arizona, United States | Recruiting |
| Mayo Clinic in Arizona - Scottsdale- Site Number : 8400014 | Scottsdale, Arizona, United States | Recruiting |
| Northridge Clinical Trials - Northridge- Site Number : 8400005 | Northridge, California, United States | Recruiting |
| FXM Clinical Research - Miami- Site Number : 8400017 | Miami, Florida, United States | Recruiting |
| FXM Clinical Research - Miramar- Site Number : 8400004 | Miramar, Florida, United States | Recruiting |
| Advanced Medical Research - Atlanta- Site Number : 8400011 | Atlanta, Georgia, United States | Recruiting |
| Georgia Skin & Cancer Clinic- Site Number : 8400009 | Savannah, Georgia, United States | Recruiting |
| The Iowa Clinic West Des Moines Campus- Site Number : 8400007 | West Des Moines, Iowa, United States | Recruiting |
| Louisiana Dermatology Associates- Site Number : 8400006 | Baton Rouge, Louisiana, United States | Recruiting |
| Washington University- Site Number : 8400010 | St Louis, Missouri, United States | Recruiting |
| JDR Dermatology Research - Site number: 8400012 | Las Vegas, Nevada, United States | Recruiting |
| Clinical Partners- Site Number : 8400002 | Johnston, Rhode Island, United States | Recruiting |
+ 67 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07170917